Adaptive Biotechnologies President and COO Julie Rubinstein sells $1.05 million in common shares
ADPT•Julie Rubinstein sold 35,228 Adaptive Biotechnologies common shares from Nov. 11-13, 2026, at prices ranging from $28.93 to $31.22 per share.
1. Share transactions
Rubinstein also exercised options for 35,228 common shares at $12.14 per share during the period. Her direct common stock holdings remained at 377,802 shares after the transactions.
